Lupin unit commissions oncology block at Vizag plant to expand CDMO biz

Drug firm Lupin has commissioned a new oncology block at its Vizag manufacturing plant. This dedicated unit will boost contract development and manufacturing services for high-potent active pharmaceutical ingredients. The facility supports clients throughout the oncology drug development lifecycle. It integrates process development and quality control labs for efficient operations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/TbUCeEN
via IFTTT